News

The companies have said they will create customised AI models and agents that Novo Nordisk can use for early research and ...
Novo Nordisk (NYSE:NVO) has teamed up with Nvidia (NASDAQ:NVDA) to integrate artificial intelligence into its drug ...
Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug ...
Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical ...
Nvidia ( NASDAQ: NVDA) announced a collaboration with Novo Nordisk ( NVO) ( OTCPK:NONOF) on Wednesday to speed up the Danish ...
Denmark-headquartered Novo Nordisk (NVO) has entered into a collaboration and exclusive worldwide license agreement with ...
Nvidia (NVDA.O) will build its first artificial intelligence cloud platform for industrial applications in Germany, CEO Jensen Huang said this week at the VivaTech conference in Paris.The technology, ...
The new multiyear agreement will allow the Danish pharma to use Gefion’s computational power to “process vast datasets” with ...
a Danish group that owns a controlling stake in Novo Nordisk, is in the process of paying roughly $90 million to Nvidia so that the chipmaker can create a new supercomputing center in Denmark.
NVIDIA GTC Paris at VivaTech — NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s ...